GMFM 1 year after continuous intrathecal baclofen infusion

Linda E. Krach, Robert L. Kriel, Richard C. Gilmartin, Dale M. Swift, Bruce B. Storrs, Ira Richmond Abbott, III, John D. Ward, Karen K. Bloom, William H. Brooks, Joseph R. Madsen, John F. McLaughlin, Joseph M. Nadell

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The purpose of this study was to assess whether there is an improvement in motor function in persons with cerebral palsy (CP) who have had a reduction of muscle tone by continuous intrathecal baclofen infusion. This was a prospective, open label, non-blinded case series without a control group, conducted at multiple centres. There were 31 subjects, aged 4-29 years. All had a pre-treatment mean lower extremity Ashworth scores of ≥3 and a significant reduction in tone after a bolus injection of intrathecal baclofen (ITB) and received an implanted pump for continuous delivery of ITB. Motor function was assessed by the Gross Motor Function Measure (GMFM) prior to and 1 year following pump implantation. Significant improvement (p<0.05) in mean GMFM scores was seen in subjects <8 years (mean change 4.1) and in those from 8-18 years (mean change 3.7) and in subjects with CP Classes 2 and 5 (mean changes 6.2 and 2.9). There was a statistically significant decrease (p<0.05) in Ashworth scores in CP classes 2-5. Subjects or their caregivers that completed a survey about perceived changes stated that motor control, positioning and endurance improved.

Original languageEnglish (US)
Pages (from-to)207-213
Number of pages7
JournalDevelopmental Neurorehabilitation
Volume8
Issue number3
DOIs
StatePublished - Jul 2005
Externally publishedYes

Fingerprint

Baclofen
Cerebral Palsy
Spinal Injections
Caregivers
Lower Extremity
Muscles
Control Groups
Therapeutics

Keywords

  • cerebral palsy
  • GMFM
  • intrathecal baclofen
  • Spasticity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Rehabilitation
  • Developmental Neuroscience

Cite this

Krach, L. E., Kriel, R. L., Gilmartin, R. C., Swift, D. M., Storrs, B. B., Abbott, III, I. R., ... Nadell, J. M. (2005). GMFM 1 year after continuous intrathecal baclofen infusion. Developmental Neurorehabilitation, 8(3), 207-213. https://doi.org/10.1080/13638490400021479

GMFM 1 year after continuous intrathecal baclofen infusion. / Krach, Linda E.; Kriel, Robert L.; Gilmartin, Richard C.; Swift, Dale M.; Storrs, Bruce B.; Abbott, III, Ira Richmond; Ward, John D.; Bloom, Karen K.; Brooks, William H.; Madsen, Joseph R.; McLaughlin, John F.; Nadell, Joseph M.

In: Developmental Neurorehabilitation, Vol. 8, No. 3, 07.2005, p. 207-213.

Research output: Contribution to journalArticle

Krach, LE, Kriel, RL, Gilmartin, RC, Swift, DM, Storrs, BB, Abbott, III, IR, Ward, JD, Bloom, KK, Brooks, WH, Madsen, JR, McLaughlin, JF & Nadell, JM 2005, 'GMFM 1 year after continuous intrathecal baclofen infusion', Developmental Neurorehabilitation, vol. 8, no. 3, pp. 207-213. https://doi.org/10.1080/13638490400021479
Krach, Linda E. ; Kriel, Robert L. ; Gilmartin, Richard C. ; Swift, Dale M. ; Storrs, Bruce B. ; Abbott, III, Ira Richmond ; Ward, John D. ; Bloom, Karen K. ; Brooks, William H. ; Madsen, Joseph R. ; McLaughlin, John F. ; Nadell, Joseph M. / GMFM 1 year after continuous intrathecal baclofen infusion. In: Developmental Neurorehabilitation. 2005 ; Vol. 8, No. 3. pp. 207-213.
@article{93c01ec2614d4579b0e557ab5d1ca26c,
title = "GMFM 1 year after continuous intrathecal baclofen infusion",
abstract = "The purpose of this study was to assess whether there is an improvement in motor function in persons with cerebral palsy (CP) who have had a reduction of muscle tone by continuous intrathecal baclofen infusion. This was a prospective, open label, non-blinded case series without a control group, conducted at multiple centres. There were 31 subjects, aged 4-29 years. All had a pre-treatment mean lower extremity Ashworth scores of ≥3 and a significant reduction in tone after a bolus injection of intrathecal baclofen (ITB) and received an implanted pump for continuous delivery of ITB. Motor function was assessed by the Gross Motor Function Measure (GMFM) prior to and 1 year following pump implantation. Significant improvement (p<0.05) in mean GMFM scores was seen in subjects <8 years (mean change 4.1) and in those from 8-18 years (mean change 3.7) and in subjects with CP Classes 2 and 5 (mean changes 6.2 and 2.9). There was a statistically significant decrease (p<0.05) in Ashworth scores in CP classes 2-5. Subjects or their caregivers that completed a survey about perceived changes stated that motor control, positioning and endurance improved.",
keywords = "cerebral palsy, GMFM, intrathecal baclofen, Spasticity",
author = "Krach, {Linda E.} and Kriel, {Robert L.} and Gilmartin, {Richard C.} and Swift, {Dale M.} and Storrs, {Bruce B.} and {Abbott, III}, {Ira Richmond} and Ward, {John D.} and Bloom, {Karen K.} and Brooks, {William H.} and Madsen, {Joseph R.} and McLaughlin, {John F.} and Nadell, {Joseph M.}",
year = "2005",
month = "7",
doi = "10.1080/13638490400021479",
language = "English (US)",
volume = "8",
pages = "207--213",
journal = "Developmental Neurorehabilitation",
issn = "1751-8423",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - GMFM 1 year after continuous intrathecal baclofen infusion

AU - Krach, Linda E.

AU - Kriel, Robert L.

AU - Gilmartin, Richard C.

AU - Swift, Dale M.

AU - Storrs, Bruce B.

AU - Abbott, III, Ira Richmond

AU - Ward, John D.

AU - Bloom, Karen K.

AU - Brooks, William H.

AU - Madsen, Joseph R.

AU - McLaughlin, John F.

AU - Nadell, Joseph M.

PY - 2005/7

Y1 - 2005/7

N2 - The purpose of this study was to assess whether there is an improvement in motor function in persons with cerebral palsy (CP) who have had a reduction of muscle tone by continuous intrathecal baclofen infusion. This was a prospective, open label, non-blinded case series without a control group, conducted at multiple centres. There were 31 subjects, aged 4-29 years. All had a pre-treatment mean lower extremity Ashworth scores of ≥3 and a significant reduction in tone after a bolus injection of intrathecal baclofen (ITB) and received an implanted pump for continuous delivery of ITB. Motor function was assessed by the Gross Motor Function Measure (GMFM) prior to and 1 year following pump implantation. Significant improvement (p<0.05) in mean GMFM scores was seen in subjects <8 years (mean change 4.1) and in those from 8-18 years (mean change 3.7) and in subjects with CP Classes 2 and 5 (mean changes 6.2 and 2.9). There was a statistically significant decrease (p<0.05) in Ashworth scores in CP classes 2-5. Subjects or their caregivers that completed a survey about perceived changes stated that motor control, positioning and endurance improved.

AB - The purpose of this study was to assess whether there is an improvement in motor function in persons with cerebral palsy (CP) who have had a reduction of muscle tone by continuous intrathecal baclofen infusion. This was a prospective, open label, non-blinded case series without a control group, conducted at multiple centres. There were 31 subjects, aged 4-29 years. All had a pre-treatment mean lower extremity Ashworth scores of ≥3 and a significant reduction in tone after a bolus injection of intrathecal baclofen (ITB) and received an implanted pump for continuous delivery of ITB. Motor function was assessed by the Gross Motor Function Measure (GMFM) prior to and 1 year following pump implantation. Significant improvement (p<0.05) in mean GMFM scores was seen in subjects <8 years (mean change 4.1) and in those from 8-18 years (mean change 3.7) and in subjects with CP Classes 2 and 5 (mean changes 6.2 and 2.9). There was a statistically significant decrease (p<0.05) in Ashworth scores in CP classes 2-5. Subjects or their caregivers that completed a survey about perceived changes stated that motor control, positioning and endurance improved.

KW - cerebral palsy

KW - GMFM

KW - intrathecal baclofen

KW - Spasticity

UR - http://www.scopus.com/inward/record.url?scp=80051940870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051940870&partnerID=8YFLogxK

U2 - 10.1080/13638490400021479

DO - 10.1080/13638490400021479

M3 - Article

VL - 8

SP - 207

EP - 213

JO - Developmental Neurorehabilitation

JF - Developmental Neurorehabilitation

SN - 1751-8423

IS - 3

ER -